Central South University Reports Findings in Breast Cancer (Interpretable Machin e Learning Algorithms Identify Inetetamab- Mediated Metabolic Signatures and Biom arkers in Treating Breast Cancer)
Central South University Reports Findings in Breast Cancer (Interpretable Machin e Learning Algorithms Identify Inetetamab- Mediated Metabolic Signatures and Biom arkers in Treating Breast Cancer)
By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews – New research on Oncology - Breast Cancer is the s ubject of a report. According to news reportingoriginating in Hunan, People’s R epublic of China, by NewsRx journalists, research stated, “HER2-positivebreast cancer (BC), a highly aggressive malignancy, has been treated with the targeted therapy inetetamabfor metastatic cases. Inetetamab (Cipterbin) is a recently ap proved targeted therapy for HER2-positivemetastatic BC, significantly prolongin g patients’ survival.”
Key words
Hunan/People’s Republic of China/Asia/Algorithms/Biomarkers/Breast Cancer/Cancer/Cyborgs/Diagnostics and Screeni ng/Emerging Technologies/Health and Medicine/Machine Learning/Oncology/Ther apy/Women’s Health
NETL
NSTL